English

CHAMPIONS ONCOLOGY, INC.

EDGAR

CSBR Current report (8-K) · filed 2026-10-16

Annual consolidated revenue for 2026: about USD 59.43M, using the latest reported figures. The previous period, 2025, was about USD 56.94M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

15.2 million USD

2027 Q1 · USD

Exact inputs and evidence

Revenue: 15232000 USD Source

Operating margin

-2.69%

2027 Q1 · %

Exact inputs and evidence

Operating Income: -409000 USD Source
Revenue: 15232000 USD Source

Operating cash flow

-492 thousand USD

2027 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -492000 USD Source

Free cash flow

-547 thousand USD

2027 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -492000 USD Source
Capital Expenditure: 55000 USD Source

Cash and cash equivalents: 4.4 million USD 2026-07-31 Source
Exact value

4400000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 13.9 million shares 2026-07-31 Source
Exact value

13918569 shares

Reported share-count change

0.94% · 130 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

13788421 shares · 2025-07-31· Source
13918569 shares · 2026-07-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

60.7 million USD

2025-08-01 – 2026-07-31

Exact inputs and evidence

Revenue: 15035000 USD · 2025-08-01 – 2025-10-31 Source
Revenue: 16559000 USD · 2025-11-01 – 2026-01-31 Source
Revenue: 59425000 USD · 2025-05-01 – 2026-04-30 Source
Revenue: 45590000 USD · 2025-05-01 – 2026-01-31 Source
Revenue: 15232000 USD · 2026-05-01 – 2026-07-31 Source

Net income

-1.1 million USD

2025-08-01 – 2026-07-31

Exact inputs and evidence

Net income: 268000 USD · 2025-08-01 – 2025-10-31 Source
Net income: -279000 USD · 2025-11-01 – 2026-01-31 Source
Net income: -1175000 USD · 2025-05-01 – 2026-04-30 Source
Net income: -508000 USD · 2025-05-01 – 2026-01-31 Source
Net income: -426000 USD · 2026-05-01 – 2026-07-31 Source

Operating cash flow

-5.56 million USD

2025-08-01 – 2026-07-31

Exact inputs and evidence

Operating cash flow: -1135000 USD · 2025-05-01 – 2025-10-31 Source
Operating cash flow: 600000 USD · 2025-05-01 – 2025-07-31 Source
Operating cash flow: -2474000 USD · 2025-05-01 – 2026-01-31 Source
Operating cash flow: -1135000 USD · 2025-05-01 – 2025-10-31 Source
Operating cash flow: -4472000 USD · 2025-05-01 – 2026-04-30 Source
Operating cash flow: -2474000 USD · 2025-05-01 – 2026-01-31 Source
Operating cash flow: -492000 USD · 2026-05-01 – 2026-07-31 Source

Capital expenditure

573 thousand USD

2025-08-01 – 2026-07-31

Exact inputs and evidence

Capital expenditure: 288000 USD · 2025-05-01 – 2025-10-31 Source
Capital expenditure: 46000 USD · 2025-05-01 – 2025-07-31 Source
Capital expenditure: 325000 USD · 2025-05-01 – 2026-01-31 Source
Capital expenditure: 288000 USD · 2025-05-01 – 2025-10-31 Source
Capital expenditure: 564000 USD · 2025-05-01 – 2026-04-30 Source
Capital expenditure: 325000 USD · 2025-05-01 – 2026-01-31 Source
Capital expenditure: 55000 USD · 2026-05-01 – 2026-07-31 Source

Free cash flow

-6.14 million USD

2025-08-01 – 2026-07-31

Exact inputs and evidence

Operating cash flow: -1135000 USD · 2025-05-01 – 2025-10-31 Source
Operating cash flow: 600000 USD · 2025-05-01 – 2025-07-31 Source
Operating cash flow: -2474000 USD · 2025-05-01 – 2026-01-31 Source
Operating cash flow: -1135000 USD · 2025-05-01 – 2025-10-31 Source
Operating cash flow: -4472000 USD · 2025-05-01 – 2026-04-30 Source
Operating cash flow: -2474000 USD · 2025-05-01 – 2026-01-31 Source
Operating cash flow: -492000 USD · 2026-05-01 – 2026-07-31 Source
Capital expenditure: 288000 USD · 2025-05-01 – 2025-10-31 Source
Capital expenditure: 46000 USD · 2025-05-01 – 2025-07-31 Source
Capital expenditure: 325000 USD · 2025-05-01 – 2026-01-31 Source
Capital expenditure: 288000 USD · 2025-05-01 – 2025-10-31 Source
Capital expenditure: 564000 USD · 2025-05-01 – 2026-04-30 Source
Capital expenditure: 325000 USD · 2025-05-01 – 2026-01-31 Source
Capital expenditure: 55000 USD · 2026-05-01 – 2026-07-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-16.

Financial data available through: 2026-04-30.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2026-04-30
Operating income: 11 of 11 periods available· newest 2026-04-30
Net income: 11 of 11 periods available· newest 2026-04-30
Operating cash flow: 11 of 11 periods available· newest 2026-04-30
Capital expenditure: 11 of 11 periods available· newest 2026-04-30
Total assets: 9 of 11 periods available· newest 2026-04-30
Total liabilities: 9 of 11 periods available· newest 2026-04-30
Current assets: 9 of 11 periods available· newest 2026-04-30
Current liabilities: 9 of 11 periods available· newest 2026-04-30
Cash and cash equivalents: 9 of 11 periods available· newest 2026-04-30
long term debt: No compatible figures in this window
Shares outstanding: 9 of 11 periods available· newest 2026-04-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+4.4%

Prior period

USD 56.94 million

2024-05-01 – 2025-04-30
Current period

USD 59.43 million

2025-05-01 – 2026-04-30

Exact inputs and evidence

59425000 − 56944000 = 2481000 USD

56944000 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source
59425000 USD · 2025-05-01 – 2026-04-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CHAMPIONS ONCOLOGY, INC. · 2026-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Year-over-year change in Revenue: 2481000 USD Concept: fundies:Revenue Period: 2025-05-01 to 2026-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 59425000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#747929 Filing: 000162828026049834 Input fundies:Revenue: 56944000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#748922 Filing: 000162828026049834
The citation records this snapshot. The page link may show a newer release later.
Net income
-125%

Prior period

USD 4.7 million

2024-05-01 – 2025-04-30
Current period

−USD 1.18 million

2025-05-01 – 2026-04-30

Exact inputs and evidence

-1175000 − 4701000 = -5876000 USD

4701000 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source
-1175000 USD · 2025-05-01 – 2026-04-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CHAMPIONS ONCOLOGY, INC. · 2026-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Year-over-year change in Net income: -5876000 USD Concept: fundies:NetIncome Period: 2025-05-01 to 2026-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1175000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#1039358 Filing: 000162828026049834 Input fundies:NetIncome: 4701000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#1040139 Filing: 000162828026049834
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-160.5%

Prior period

USD 7.39 million

2024-05-01 – 2025-04-30
Current period

−USD 4.47 million

2025-05-01 – 2026-04-30

Exact inputs and evidence

-4472000 − 7386000 = -11858000 USD

7386000 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source
-4472000 USD · 2025-05-01 – 2026-04-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CHAMPIONS ONCOLOGY, INC. · 2026-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Year-over-year change in Operating cash flow: -11858000 USD Concept: fundies:OperatingCashFlow Period: 2025-05-01 to 2026-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4472000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#575269 Filing: 000162828026049834 Input fundies:OperatingCashFlow: 7386000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#575875 Filing: 000162828026049834
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+45%

Prior period

USD 389,000

2024-05-01 – 2025-04-30
Current period

USD 564,000

2025-05-01 – 2026-04-30

Exact inputs and evidence

564000 − 389000 = 175000 USD

389000 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source
564000 USD · 2025-05-01 – 2026-04-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CHAMPIONS ONCOLOGY, INC. · 2026-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Year-over-year change in Capital expenditure: 175000 USD Concept: fundies:CapitalExpenditure Period: 2025-05-01 to 2026-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 564000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#577835 Filing: 000162828026049834 Input fundies:CapitalExpenditure: 389000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#578402 Filing: 000162828026049834
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-05-01 – 2026-04-30

Revenue USD 59.43 million 100% of revenue
Operating costs Derived USD 60.57 million 102% of revenue
Operating income −USD 1.14 million −1.9% of revenue
Tax, interest and other Derived USD 35,000 0.1% of revenue
Net income −USD 1.18 million −2% of revenue

Cash

Operating cash flow −USD 4.47 million −7.5% of revenue
Capital expenditure USD 564,000 0.9% of revenue
Free cash flow Derived −USD 5.04 million −8.5% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Operating loss: operating costs were 107% of revenue.
2019 91%
2020 Operating loss: operating costs were 106% of revenue.
2021 99%
2022 99%
2023 Operating loss: operating costs were 110% of revenue.
2024 Operating loss: operating costs were 115% of revenue.
2025 Net income was higher than operating income, so the split is not drawn.
2026 Operating loss: operating costs were 102% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2017-05-01 – 2018-04-30	20241000	21595000 Derived	-1354000	122000 Derived	-1476000	-2455000 Derived	Source 2017-05-01 – 2018-04-30: 20241000 USD Inspect Revenue Open source 2017-05-01 – 2018-04-30: -1354000 USD Inspect Operating Income Open source 2017-05-01 – 2018-04-30: -1476000 USD Inspect Net Income Open source 2017-05-01 – 2018-04-30: -1226000 USD Inspect Operating Cash Flow Open source 2017-05-01 – 2018-04-30: 1229000 USD Inspect Capital Expenditure Open source
2019 2018-05-01 – 2019-04-30	2900000	2630000 Derived	270000	142000 Derived	128000	1028000 Derived	Source 2018-05-01 – 2019-04-30: 2900000 USD Inspect Revenue Open source 2018-05-01 – 2019-04-30: 270000 USD Inspect Operating Income Open source 2018-05-01 – 2019-04-30: 128000 USD Inspect Net Income Open source 2018-05-01 – 2019-04-30: 1862000 USD Inspect Operating Cash Flow Open source 2018-05-01 – 2019-04-30: 834000 USD Inspect Capital Expenditure Open source
2020 2019-05-01 – 2020-04-30	32123000	34044000 Derived	-1921000	172000 Derived	-2093000	685000 Derived	Source 2019-05-01 – 2020-04-30: 32123000 USD Inspect Revenue Open source 2019-05-01 – 2020-04-30: -1921000 USD Inspect Operating Income Open source 2019-05-01 – 2020-04-30: -2093000 USD Inspect Net Income Open source 2019-05-01 – 2020-04-30: 2905000 USD Inspect Operating Cash Flow Open source 2019-05-01 – 2020-04-30: 2220000 USD Inspect Capital Expenditure Open source
2021 2020-05-01 – 2021-04-30	41040000	40674000 Derived	366000	4000 Derived	362000	-4962000 Derived	Source 2020-05-01 – 2021-04-30: 41040000 USD Inspect Revenue Open source 2020-05-01 – 2021-04-30: 366000 USD Inspect Operating Income Open source 2020-05-01 – 2021-04-30: 362000 USD Inspect Net Income Open source 2020-05-01 – 2021-04-30: -1681000 USD Inspect Operating Cash Flow Open source 2020-05-01 – 2021-04-30: 3281000 USD Inspect Capital Expenditure Open source
2022 2021-05-01 – 2022-04-30	49109000	48502000 Derived	607000	59000 Derived	548000	4113000 Derived	Source 2021-05-01 – 2022-04-30: 49109000 USD Inspect Revenue Open source 2021-05-01 – 2022-04-30: 607000 USD Inspect Operating Income Open source 2021-05-01 – 2022-04-30: 548000 USD Inspect Net Income Open source 2021-05-01 – 2022-04-30: 6497000 USD Inspect Operating Cash Flow Open source 2021-05-01 – 2022-04-30: 2384000 USD Inspect Capital Expenditure Open source
2023 2022-05-01 – 2023-04-30	53870000	59126000 Derived	-5256000	79000 Derived	-5335000	1100000 Derived	Source 2022-05-01 – 2023-04-30: 53870000 USD Inspect Revenue Open source 2022-05-01 – 2023-04-30: -5256000 USD Inspect Operating Income Open source 2022-05-01 – 2023-04-30: -5335000 USD Inspect Net Income Open source 2022-05-01 – 2023-04-30: 3972000 USD Inspect Operating Cash Flow Open source 2022-05-01 – 2023-04-30: 2872000 USD Inspect Capital Expenditure Open source
2024 2023-05-01 – 2024-04-30	50155000	57511000 Derived	-7356000	-80000 Derived	-7276000	-6973000 Derived	Source 2023-05-01 – 2024-04-30: 50155000 USD Inspect Revenue Open source 2023-05-01 – 2024-04-30: -7356000 USD Inspect Operating Income Open source 2023-05-01 – 2024-04-30: -7276000 USD Inspect Net Income Open source 2023-05-01 – 2024-04-30: -6137000 USD Inspect Operating Cash Flow Open source 2023-05-01 – 2024-04-30: 836000 USD Inspect Capital Expenditure Open source
2025 2024-05-01 – 2025-04-30	56944000	52391000 Derived	4553000	-148000 Derived	4701000	6997000 Derived	Source 2024-05-01 – 2025-04-30: 56944000 USD Inspect Revenue Open source 2024-05-01 – 2025-04-30: 4553000 USD Inspect Operating Income Open source 2024-05-01 – 2025-04-30: 4701000 USD Inspect Net Income Open source 2024-05-01 – 2025-04-30: 7386000 USD Inspect Operating Cash Flow Open source 2024-05-01 – 2025-04-30: 389000 USD Inspect Capital Expenditure Open source
2026 2025-05-01 – 2026-04-30	59425000	60565000 Derived	-1140000	35000 Derived	-1175000	-5036000 Derived	Source 2025-05-01 – 2026-04-30: 59425000 USD Inspect Revenue Open source 2025-05-01 – 2026-04-30: -1140000 USD Inspect Operating Income Open source 2025-05-01 – 2026-04-30: -1175000 USD Inspect Net Income Open source 2025-05-01 – 2026-04-30: -4472000 USD Inspect Operating Cash Flow Open source 2025-05-01 – 2026-04-30: 564000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 59.4M 2026

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-04-30	Revenue	20241000	Revenue: 20241000 Open source
20192019-04-30	Revenue	2900000	Revenue: 2900000 Open source
20202020-04-30	Revenue	32123000	Revenue: 32123000 Open source
20212021-04-30	Revenue	41040000	Revenue: 41040000 Open source
20222022-04-30	Revenue	49109000	Revenue: 49109000 Open source
20232023-04-30	Revenue	53870000	Revenue: 53870000 Open source
20242024-04-30	Revenue	50155000	Revenue: 50155000 Open source
20252025-04-30	Revenue	56944000	Revenue: 56944000 Open source
20262026-04-30	Revenue	59425000	Revenue: 59425000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

4.4% 2026

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-04-30	Year over year	No prior comparable period	Revenue: 20241000 Open source
20192019-04-30	Year over year	-85.7%	Revenue: 2900000 Open source Revenue: 20241000 Open source
20202020-04-30	Year over year	1,007.7%	Revenue: 32123000 Open source Revenue: 2900000 Open source
20212021-04-30	Year over year	27.8%	Revenue: 41040000 Open source Revenue: 32123000 Open source
20222022-04-30	Year over year	19.7%	Revenue: 49109000 Open source Revenue: 41040000 Open source
20232023-04-30	Year over year	9.7%	Revenue: 53870000 Open source Revenue: 49109000 Open source
20242024-04-30	Year over year	-6.9%	Revenue: 50155000 Open source Revenue: 53870000 Open source
20252025-04-30	Year over year	13.5%	Revenue: 56944000 Open source Revenue: 50155000 Open source
20262026-04-30	Year over year	4.4%	Revenue: 59425000 Open source Revenue: 56944000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1.9% 2026

Net margin -2% 2026

Free cash flow margin -8.5% 2026

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-04-30	Operating margin	-6.7%	Operating Income: -1354000 Open source Revenue: 20241000 Open source
20192019-04-30	Operating margin	9.3%	Operating Income: 270000 Open source Revenue: 2900000 Open source
20202020-04-30	Operating margin	-6%	Operating Income: -1921000 Open source Revenue: 32123000 Open source
20212021-04-30	Operating margin	0.9%	Operating Income: 366000 Open source Revenue: 41040000 Open source
20222022-04-30	Operating margin	1.2%	Operating Income: 607000 Open source Revenue: 49109000 Open source
20232023-04-30	Operating margin	-9.8%	Operating Income: -5256000 Open source Revenue: 53870000 Open source
20242024-04-30	Operating margin	-14.7%	Operating Income: -7356000 Open source Revenue: 50155000 Open source
20252025-04-30	Operating margin	8%	Operating Income: 4553000 Open source Revenue: 56944000 Open source
20262026-04-30	Operating margin	-1.9%	Operating Income: -1140000 Open source Revenue: 59425000 Open source
20182018-04-30	Net margin	-7.3%	Net Income: -1476000 Open source Revenue: 20241000 Open source
20192019-04-30	Net margin	4.4%	Net Income: 128000 Open source Revenue: 2900000 Open source
20202020-04-30	Net margin	-6.5%	Net Income: -2093000 Open source Revenue: 32123000 Open source
20212021-04-30	Net margin	0.9%	Net Income: 362000 Open source Revenue: 41040000 Open source
20222022-04-30	Net margin	1.1%	Net Income: 548000 Open source Revenue: 49109000 Open source
20232023-04-30	Net margin	-9.9%	Net Income: -5335000 Open source Revenue: 53870000 Open source
20242024-04-30	Net margin	-14.5%	Net Income: -7276000 Open source Revenue: 50155000 Open source
20252025-04-30	Net margin	8.3%	Net Income: 4701000 Open source Revenue: 56944000 Open source
20262026-04-30	Net margin	-2%	Net Income: -1175000 Open source Revenue: 59425000 Open source
20182018-04-30	Free cash flow margin	-12.1%	Revenue: 20241000 Open source Operating Cash Flow: -1226000 Open source Capital Expenditure: 1229000 Open source
20192019-04-30	Free cash flow margin	35.4%	Revenue: 2900000 Open source Operating Cash Flow: 1862000 Open source Capital Expenditure: 834000 Open source
20202020-04-30	Free cash flow margin	2.1%	Revenue: 32123000 Open source Operating Cash Flow: 2905000 Open source Capital Expenditure: 2220000 Open source
20212021-04-30	Free cash flow margin	-12.1%	Revenue: 41040000 Open source Operating Cash Flow: -1681000 Open source Capital Expenditure: 3281000 Open source
20222022-04-30	Free cash flow margin	8.4%	Revenue: 49109000 Open source Operating Cash Flow: 6497000 Open source Capital Expenditure: 2384000 Open source
20232023-04-30	Free cash flow margin	2%	Revenue: 53870000 Open source Operating Cash Flow: 3972000 Open source Capital Expenditure: 2872000 Open source
20242024-04-30	Free cash flow margin	-13.9%	Revenue: 50155000 Open source Operating Cash Flow: -6137000 Open source Capital Expenditure: 836000 Open source
20252025-04-30	Free cash flow margin	12.3%	Revenue: 56944000 Open source Operating Cash Flow: 7386000 Open source Capital Expenditure: 389000 Open source
20262026-04-30	Free cash flow margin	-8.5%	Revenue: 59425000 Open source Operating Cash Flow: -4472000 Open source Capital Expenditure: 564000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.5M 2026

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-04-30	Operating cash flow	-1226000	Operating Cash Flow: -1226000 Open source
20192019-04-30	Operating cash flow	1862000	Operating Cash Flow: 1862000 Open source
20202020-04-30	Operating cash flow	2905000	Operating Cash Flow: 2905000 Open source
20212021-04-30	Operating cash flow	-1681000	Operating Cash Flow: -1681000 Open source
20222022-04-30	Operating cash flow	6497000	Operating Cash Flow: 6497000 Open source
20232023-04-30	Operating cash flow	3972000	Operating Cash Flow: 3972000 Open source
20242024-04-30	Operating cash flow	-6137000	Operating Cash Flow: -6137000 Open source
20252025-04-30	Operating cash flow	7386000	Operating Cash Flow: 7386000 Open source
20262026-04-30	Operating cash flow	-4472000	Operating Cash Flow: -4472000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -5M 2026

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-04-30	Free cash flow	-2455000	Operating Cash Flow: -1226000 Open source Capital Expenditure: 1229000 Open source
20192019-04-30	Free cash flow	1028000	Operating Cash Flow: 1862000 Open source Capital Expenditure: 834000 Open source
20202020-04-30	Free cash flow	685000	Operating Cash Flow: 2905000 Open source Capital Expenditure: 2220000 Open source
20212021-04-30	Free cash flow	-4962000	Operating Cash Flow: -1681000 Open source Capital Expenditure: 3281000 Open source
20222022-04-30	Free cash flow	4113000	Operating Cash Flow: 6497000 Open source Capital Expenditure: 2384000 Open source
20232023-04-30	Free cash flow	1100000	Operating Cash Flow: 3972000 Open source Capital Expenditure: 2872000 Open source
20242024-04-30	Free cash flow	-6973000	Operating Cash Flow: -6137000 Open source Capital Expenditure: 836000 Open source
20252025-04-30	Free cash flow	6997000	Operating Cash Flow: 7386000 Open source Capital Expenditure: 389000 Open source
20262026-04-30	Free cash flow	-5036000	Operating Cash Flow: -4472000 Open source Capital Expenditure: 564000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

84.9% 2026

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20182018-04-30	Liabilities / assets	100%	Total Liabilities: 8075000 Open source Total Assets: 8078000 Open source
20192019-04-30	Liabilities / assets	80.1%	Total Liabilities: 9027000 Open source Total Assets: 11265000 Open source
20202020-04-30	Liabilities / assets	75.4%	Total Liabilities: 15652000 Open source Total Assets: 20751000 Open source
20212021-04-30	Liabilities / assets	73.1%	Total Liabilities: 20163000 Open source Total Assets: 27591000 Open source
20222022-04-30	Liabilities / assets	74.3%	Total Liabilities: 26282000 Open source Total Assets: 35378000 Open source
20232023-04-30	Liabilities / assets	86.5%	Total Liabilities: 29675000 Open source Total Assets: 34311000 Open source
20242024-04-30	Liabilities / assets	107.3%	Total Liabilities: 28035000 Open source Total Assets: 26132000 Open source
20252025-04-30	Liabilities / assets	88.3%	Total Liabilities: 28572000 Open source Total Assets: 32344000 Open source
20262026-04-30	Liabilities / assets	84.9%	Total Liabilities: 22921000 Open source Total Assets: 26989000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.96× 2026

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20182018-04-30	Current assets / current liabilities	0.68×	Current Assets: 5060000 Open source Current Liabilities: 7453000 Open source
20192019-04-30	Current assets / current liabilities	0.99×	Current Assets: 7922000 Open source Current Liabilities: 8025000 Open source
20202020-04-30	Current assets / current liabilities	1.1×	Current Assets: 13497000 Open source Current Liabilities: 12304000 Open source
20212021-04-30	Current assets / current liabilities	1.13×	Current Assets: 12630000 Open source Current Liabilities: 11199000 Open source
20222022-04-30	Current assets / current liabilities	1.13×	Current Assets: 19664000 Open source Current Liabilities: 17479000 Open source
20232023-04-30	Current assets / current liabilities	0.9×	Current Assets: 19457000 Open source Current Liabilities: 21733000 Open source
20242024-04-30	Current assets / current liabilities	0.63×	Current Assets: 13639000 Open source Current Liabilities: 21541000 Open source
20252025-04-30	Current assets / current liabilities	0.94×	Current Assets: 22358000 Open source Current Liabilities: 23853000 Open source
20262026-04-30	Current assets / current liabilities	0.96×	Current Assets: 19219000 Open source Current Liabilities: 19922000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-05-01 – 2017-04-30	−USD 6.9 million Exact value Exact value: -6900000 USD 2016-05-01 – 2017-04-30: -6900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2017-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: -6900000 USD Concept: fundies:NetIncome Period: 2016-05-01 to 2017-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2017-04-30&surface=latest&period_type=duration&start=2016-05-01&unit=USD&dimensions= Input fundies:NetIncome: -6900000 USD (2016-05-01 to 2017-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828018009773/csbr-20180430.xml#122306 Filing: 000162828018009773 The citation records this snapshot. The page link may show a newer release later.	−USD 2.84 million Exact value Exact value: -2840000 USD 2016-05-01 – 2017-04-30: -2840000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2017-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: -2840000 USD Concept: fundies:OperatingCashFlow Period: 2016-05-01 to 2017-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2017-04-30&surface=latest&period_type=duration&start=2016-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2840000 USD (2016-05-01 to 2017-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828018009773/csbr-20180430.xml#121731 Filing: 000162828018009773 The citation records this snapshot. The page link may show a newer release later.	USD 766,000 Exact value Exact value: 766000 USD 2016-05-01 – 2017-04-30: 766000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2017-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 766000 USD Concept: fundies:CapitalExpenditure Period: 2016-05-01 to 2017-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2017-04-30&surface=latest&period_type=duration&start=2016-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 766000 USD (2016-05-01 to 2017-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828018009773/csbr-20180430.xml#128275 Filing: 000162828018009773 The citation records this snapshot. The page link may show a newer release later.	−USD 3.61 million Calculation and evidence -2840000 − 766000 USD Exact free cash flow: -3606000 USD 2016-05-01 – 2017-04-30: -2840000 USD · Inspect Operating Cash Flow · Source 2016-05-01 – 2017-04-30: 766000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2017-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: -3606000 USD Concept: free-cash-flow Period: 2016-05-01 to 2017-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2840000 USD (2016-05-01 to 2017-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828018009773/csbr-20180430.xml#121731 Filing: 000162828018009773 Input fundies:CapitalExpenditure: 766000 USD (2016-05-01 to 2017-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828018009773/csbr-20180430.xml#128275 Filing: 000162828018009773 The citation records this snapshot. The page link may show a newer release later.
2018 2017-05-01 – 2018-04-30	−USD 1.48 million Exact value Exact value: -1476000 USD 2017-05-01 – 2018-04-30: -1476000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2018-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: -1476000 USD Concept: fundies:NetIncome Period: 2017-05-01 to 2018-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2018-04-30&surface=latest&period_type=duration&start=2017-05-01&unit=USD&dimensions= Input fundies:NetIncome: -1476000 USD (2017-05-01 to 2018-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828019009139/csbr-20190430.xml#139267 Filing: 000162828019009139 The citation records this snapshot. The page link may show a newer release later.	−USD 1.23 million Exact value Exact value: -1226000 USD 2017-05-01 – 2018-04-30: -1226000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2018-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: -1226000 USD Concept: fundies:OperatingCashFlow Period: 2017-05-01 to 2018-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2018-04-30&surface=latest&period_type=duration&start=2017-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1226000 USD (2017-05-01 to 2018-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828019009139/csbr-20190430.xml#138846 Filing: 000162828019009139 The citation records this snapshot. The page link may show a newer release later.	USD 1.23 million Exact value Exact value: 1229000 USD 2017-05-01 – 2018-04-30: 1229000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2018-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 1229000 USD Concept: fundies:CapitalExpenditure Period: 2017-05-01 to 2018-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2018-04-30&surface=latest&period_type=duration&start=2017-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1229000 USD (2017-05-01 to 2018-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828019009139/csbr-20190430.xml#145691 Filing: 000162828019009139 The citation records this snapshot. The page link may show a newer release later.	−USD 2.46 million Calculation and evidence -1226000 − 1229000 USD Exact free cash flow: -2455000 USD 2017-05-01 – 2018-04-30: -1226000 USD · Inspect Operating Cash Flow · Source 2017-05-01 – 2018-04-30: 1229000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2018-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: -2455000 USD Concept: free-cash-flow Period: 2017-05-01 to 2018-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1226000 USD (2017-05-01 to 2018-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828019009139/csbr-20190430.xml#138846 Filing: 000162828019009139 Input fundies:CapitalExpenditure: 1229000 USD (2017-05-01 to 2018-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828019009139/csbr-20190430.xml#145691 Filing: 000162828019009139 The citation records this snapshot. The page link may show a newer release later.
2019 2018-05-01 – 2019-04-30	USD 128,000 Exact value Exact value: 128000 USD 2018-05-01 – 2019-04-30: 128000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2019-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: 128000 USD Concept: fundies:NetIncome Period: 2018-05-01 to 2019-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2019-04-30&surface=latest&period_type=duration&start=2018-05-01&unit=USD&dimensions= Input fundies:NetIncome: 128000 USD (2018-05-01 to 2019-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828020010734/csbr-20200430.xml#141107 Filing: 000162828020010734 The citation records this snapshot. The page link may show a newer release later.	USD 1.86 million Exact value Exact value: 1862000 USD 2018-05-01 – 2019-04-30: 1862000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2019-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: 1862000 USD Concept: fundies:OperatingCashFlow Period: 2018-05-01 to 2019-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2019-04-30&surface=latest&period_type=duration&start=2018-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1862000 USD (2018-05-01 to 2019-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828020010734/csbr-20200430.xml#140687 Filing: 000162828020010734 The citation records this snapshot. The page link may show a newer release later.	USD 834,000 Exact value Exact value: 834000 USD 2018-05-01 – 2019-04-30: 834000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2019-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 834000 USD Concept: fundies:CapitalExpenditure Period: 2018-05-01 to 2019-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2019-04-30&surface=latest&period_type=duration&start=2018-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 834000 USD (2018-05-01 to 2019-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828020010734/csbr-20200430.xml#151193 Filing: 000162828020010734 The citation records this snapshot. The page link may show a newer release later.	USD 1.03 million Calculation and evidence 1862000 − 834000 USD Exact free cash flow: 1028000 USD 2018-05-01 – 2019-04-30: 1862000 USD · Inspect Operating Cash Flow · Source 2018-05-01 – 2019-04-30: 834000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2019-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: 1028000 USD Concept: free-cash-flow Period: 2018-05-01 to 2019-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1862000 USD (2018-05-01 to 2019-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828020010734/csbr-20200430.xml#140687 Filing: 000162828020010734 Input fundies:CapitalExpenditure: 834000 USD (2018-05-01 to 2019-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828020010734/csbr-20200430.xml#151193 Filing: 000162828020010734 The citation records this snapshot. The page link may show a newer release later.
2020 2019-05-01 – 2020-04-30	−USD 2.09 million Exact value Exact value: -2093000 USD 2019-05-01 – 2020-04-30: -2093000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2020-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: -2093000 USD Concept: fundies:NetIncome Period: 2019-05-01 to 2020-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2020-04-30&surface=latest&period_type=duration&start=2019-05-01&unit=USD&dimensions= Input fundies:NetIncome: -2093000 USD (2019-05-01 to 2020-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828021014464/csbr-20210430.htm#1391976 Filing: 000162828021014464 The citation records this snapshot. The page link may show a newer release later.	USD 2.91 million Exact value Exact value: 2905000 USD 2019-05-01 – 2020-04-30: 2905000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2020-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: 2905000 USD Concept: fundies:OperatingCashFlow Period: 2019-05-01 to 2020-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2020-04-30&surface=latest&period_type=duration&start=2019-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2905000 USD (2019-05-01 to 2020-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828021014464/csbr-20210430.htm#721553 Filing: 000162828021014464 The citation records this snapshot. The page link may show a newer release later.	USD 2.22 million Exact value Exact value: 2220000 USD 2019-05-01 – 2020-04-30: 2220000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2020-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 2220000 USD Concept: fundies:CapitalExpenditure Period: 2019-05-01 to 2020-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2020-04-30&surface=latest&period_type=duration&start=2019-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2220000 USD (2019-05-01 to 2020-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828021014464/csbr-20210430.htm#724905 Filing: 000162828021014464 The citation records this snapshot. The page link may show a newer release later.	USD 685,000 Calculation and evidence 2905000 − 2220000 USD Exact free cash flow: 685000 USD 2019-05-01 – 2020-04-30: 2905000 USD · Inspect Operating Cash Flow · Source 2019-05-01 – 2020-04-30: 2220000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2020-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: 685000 USD Concept: free-cash-flow Period: 2019-05-01 to 2020-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2905000 USD (2019-05-01 to 2020-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828021014464/csbr-20210430.htm#721553 Filing: 000162828021014464 Input fundies:CapitalExpenditure: 2220000 USD (2019-05-01 to 2020-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828021014464/csbr-20210430.htm#724905 Filing: 000162828021014464 The citation records this snapshot. The page link may show a newer release later.
2021 2020-05-01 – 2021-04-30	USD 362,000 Exact value Exact value: 362000 USD 2020-05-01 – 2021-04-30: 362000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2021-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: 362000 USD Concept: fundies:NetIncome Period: 2020-05-01 to 2021-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2021-04-30&surface=latest&period_type=duration&start=2020-05-01&unit=USD&dimensions= Input fundies:NetIncome: 362000 USD (2020-05-01 to 2021-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828022019309/csbr-20220430.htm#1166651 Filing: 000162828022019309 The citation records this snapshot. The page link may show a newer release later.	−USD 1.68 million Exact value Exact value: -1681000 USD 2020-05-01 – 2021-04-30: -1681000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2021-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: -1681000 USD Concept: fundies:OperatingCashFlow Period: 2020-05-01 to 2021-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2021-04-30&surface=latest&period_type=duration&start=2020-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1681000 USD (2020-05-01 to 2021-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828022019309/csbr-20220430.htm#683075 Filing: 000162828022019309 The citation records this snapshot. The page link may show a newer release later.	USD 3.28 million Exact value Exact value: 3281000 USD 2020-05-01 – 2021-04-30: 3281000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2021-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 3281000 USD Concept: fundies:CapitalExpenditure Period: 2020-05-01 to 2021-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2021-04-30&surface=latest&period_type=duration&start=2020-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3281000 USD (2020-05-01 to 2021-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828022019309/csbr-20220430.htm#686445 Filing: 000162828022019309 The citation records this snapshot. The page link may show a newer release later.	−USD 4.96 million Calculation and evidence -1681000 − 3281000 USD Exact free cash flow: -4962000 USD 2020-05-01 – 2021-04-30: -1681000 USD · Inspect Operating Cash Flow · Source 2020-05-01 – 2021-04-30: 3281000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2021-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: -4962000 USD Concept: free-cash-flow Period: 2020-05-01 to 2021-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1681000 USD (2020-05-01 to 2021-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828022019309/csbr-20220430.htm#683075 Filing: 000162828022019309 Input fundies:CapitalExpenditure: 3281000 USD (2020-05-01 to 2021-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828022019309/csbr-20220430.htm#686445 Filing: 000162828022019309 The citation records this snapshot. The page link may show a newer release later.
2022 2021-05-01 – 2022-04-30	USD 548,000 Exact value Exact value: 548000 USD 2021-05-01 – 2022-04-30: 548000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2022-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: 548000 USD Concept: fundies:NetIncome Period: 2021-05-01 to 2022-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2022-04-30&surface=latest&period_type=duration&start=2021-05-01&unit=USD&dimensions= Input fundies:NetIncome: 548000 USD (2021-05-01 to 2022-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828023025464/csbr-20230430.htm#968905 Filing: 000162828023025464 The citation records this snapshot. The page link may show a newer release later.	USD 6.5 million Exact value Exact value: 6497000 USD 2021-05-01 – 2022-04-30: 6497000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2022-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: 6497000 USD Concept: fundies:OperatingCashFlow Period: 2021-05-01 to 2022-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2022-04-30&surface=latest&period_type=duration&start=2021-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6497000 USD (2021-05-01 to 2022-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828023025464/csbr-20230430.htm#606582 Filing: 000162828023025464 The citation records this snapshot. The page link may show a newer release later.	USD 2.38 million Exact value Exact value: 2384000 USD 2021-05-01 – 2022-04-30: 2384000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2022-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 2384000 USD Concept: fundies:CapitalExpenditure Period: 2021-05-01 to 2022-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2022-04-30&surface=latest&period_type=duration&start=2021-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2384000 USD (2021-05-01 to 2022-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828023025464/csbr-20230430.htm#609176 Filing: 000162828023025464 The citation records this snapshot. The page link may show a newer release later.	USD 4.11 million Calculation and evidence 6497000 − 2384000 USD Exact free cash flow: 4113000 USD 2021-05-01 – 2022-04-30: 6497000 USD · Inspect Operating Cash Flow · Source 2021-05-01 – 2022-04-30: 2384000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2022-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: 4113000 USD Concept: free-cash-flow Period: 2021-05-01 to 2022-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6497000 USD (2021-05-01 to 2022-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828023025464/csbr-20230430.htm#606582 Filing: 000162828023025464 Input fundies:CapitalExpenditure: 2384000 USD (2021-05-01 to 2022-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828023025464/csbr-20230430.htm#609176 Filing: 000162828023025464 The citation records this snapshot. The page link may show a newer release later.
2023 2022-05-01 – 2023-04-30	−USD 5.34 million Exact value Exact value: -5335000 USD 2022-05-01 – 2023-04-30: -5335000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2023-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: -5335000 USD Concept: fundies:NetIncome Period: 2022-05-01 to 2023-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2023-04-30&surface=latest&period_type=duration&start=2022-05-01&unit=USD&dimensions= Input fundies:NetIncome: -5335000 USD (2022-05-01 to 2023-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828024032321/csbr-20240430.htm#1000633 Filing: 000162828024032321 The citation records this snapshot. The page link may show a newer release later.	USD 3.97 million Exact value Exact value: 3972000 USD 2022-05-01 – 2023-04-30: 3972000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2023-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: 3972000 USD Concept: fundies:OperatingCashFlow Period: 2022-05-01 to 2023-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2023-04-30&surface=latest&period_type=duration&start=2022-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3972000 USD (2022-05-01 to 2023-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828024032321/csbr-20240430.htm#631242 Filing: 000162828024032321 The citation records this snapshot. The page link may show a newer release later.	USD 2.87 million Exact value Exact value: 2872000 USD 2022-05-01 – 2023-04-30: 2872000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2023-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 2872000 USD Concept: fundies:CapitalExpenditure Period: 2022-05-01 to 2023-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2023-04-30&surface=latest&period_type=duration&start=2022-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2872000 USD (2022-05-01 to 2023-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828024032321/csbr-20240430.htm#633773 Filing: 000162828024032321 The citation records this snapshot. The page link may show a newer release later.	USD 1.1 million Calculation and evidence 3972000 − 2872000 USD Exact free cash flow: 1100000 USD 2022-05-01 – 2023-04-30: 3972000 USD · Inspect Operating Cash Flow · Source 2022-05-01 – 2023-04-30: 2872000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2023-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: 1100000 USD Concept: free-cash-flow Period: 2022-05-01 to 2023-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3972000 USD (2022-05-01 to 2023-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828024032321/csbr-20240430.htm#631242 Filing: 000162828024032321 Input fundies:CapitalExpenditure: 2872000 USD (2022-05-01 to 2023-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828024032321/csbr-20240430.htm#633773 Filing: 000162828024032321 The citation records this snapshot. The page link may show a newer release later.
2024 2023-05-01 – 2024-04-30	−USD 7.28 million Exact value Exact value: -7276000 USD 2023-05-01 – 2024-04-30: -7276000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2024-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: -7276000 USD Concept: fundies:NetIncome Period: 2023-05-01 to 2024-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2024-04-30&surface=latest&period_type=duration&start=2023-05-01&unit=USD&dimensions= Input fundies:NetIncome: -7276000 USD (2023-05-01 to 2024-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828025035765/csbr-20250430.htm#931702 Filing: 000162828025035765 The citation records this snapshot. The page link may show a newer release later.	−USD 6.14 million Exact value Exact value: -6137000 USD 2023-05-01 – 2024-04-30: -6137000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2024-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: -6137000 USD Concept: fundies:OperatingCashFlow Period: 2023-05-01 to 2024-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2024-04-30&surface=latest&period_type=duration&start=2023-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6137000 USD (2023-05-01 to 2024-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828025035765/csbr-20250430.htm#565146 Filing: 000162828025035765 The citation records this snapshot. The page link may show a newer release later.	USD 836,000 Exact value Exact value: 836000 USD 2023-05-01 – 2024-04-30: 836000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2024-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 836000 USD Concept: fundies:CapitalExpenditure Period: 2023-05-01 to 2024-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2024-04-30&surface=latest&period_type=duration&start=2023-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 836000 USD (2023-05-01 to 2024-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828025035765/csbr-20250430.htm#567651 Filing: 000162828025035765 The citation records this snapshot. The page link may show a newer release later.	−USD 6.97 million Calculation and evidence -6137000 − 836000 USD Exact free cash flow: -6973000 USD 2023-05-01 – 2024-04-30: -6137000 USD · Inspect Operating Cash Flow · Source 2023-05-01 – 2024-04-30: 836000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2024-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: -6973000 USD Concept: free-cash-flow Period: 2023-05-01 to 2024-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6137000 USD (2023-05-01 to 2024-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828025035765/csbr-20250430.htm#565146 Filing: 000162828025035765 Input fundies:CapitalExpenditure: 836000 USD (2023-05-01 to 2024-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828025035765/csbr-20250430.htm#567651 Filing: 000162828025035765 The citation records this snapshot. The page link may show a newer release later.
2025 2024-05-01 – 2025-04-30	USD 4.7 million Exact value Exact value: 4701000 USD 2024-05-01 – 2025-04-30: 4701000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2025-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: 4701000 USD Concept: fundies:NetIncome Period: 2024-05-01 to 2025-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2025-04-30&surface=latest&period_type=duration&start=2024-05-01&unit=USD&dimensions= Input fundies:NetIncome: 4701000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#1040139 Filing: 000162828026049834 The citation records this snapshot. The page link may show a newer release later.	USD 7.39 million Exact value Exact value: 7386000 USD 2024-05-01 – 2025-04-30: 7386000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2025-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: 7386000 USD Concept: fundies:OperatingCashFlow Period: 2024-05-01 to 2025-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2025-04-30&surface=latest&period_type=duration&start=2024-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7386000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#575875 Filing: 000162828026049834 The citation records this snapshot. The page link may show a newer release later.	USD 389,000 Exact value Exact value: 389000 USD 2024-05-01 – 2025-04-30: 389000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2025-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 389000 USD Concept: fundies:CapitalExpenditure Period: 2024-05-01 to 2025-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2025-04-30&surface=latest&period_type=duration&start=2024-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 389000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#578402 Filing: 000162828026049834 The citation records this snapshot. The page link may show a newer release later.	USD 7 million Calculation and evidence 7386000 − 389000 USD Exact free cash flow: 6997000 USD 2024-05-01 – 2025-04-30: 7386000 USD · Inspect Operating Cash Flow · Source 2024-05-01 – 2025-04-30: 389000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2025-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: 6997000 USD Concept: free-cash-flow Period: 2024-05-01 to 2025-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7386000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#575875 Filing: 000162828026049834 Input fundies:CapitalExpenditure: 389000 USD (2024-05-01 to 2025-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#578402 Filing: 000162828026049834 The citation records this snapshot. The page link may show a newer release later.
2026 2025-05-01 – 2026-04-30	−USD 1.18 million Exact value Exact value: -1175000 USD 2025-05-01 – 2026-04-30: -1175000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHAMPIONS ONCOLOGY, INC. · 2026-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Net Income: -1175000 USD Concept: fundies:NetIncome Period: 2025-05-01 to 2026-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ANetIncome&period=2026-04-30&surface=latest&period_type=duration&start=2025-05-01&unit=USD&dimensions= Input fundies:NetIncome: -1175000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#1039358 Filing: 000162828026049834 The citation records this snapshot. The page link may show a newer release later.	−USD 4.47 million Exact value Exact value: -4472000 USD 2025-05-01 – 2026-04-30: -4472000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHAMPIONS ONCOLOGY, INC. · 2026-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Operating Cash Flow: -4472000 USD Concept: fundies:OperatingCashFlow Period: 2025-05-01 to 2026-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3AOperatingCashFlow&period=2026-04-30&surface=latest&period_type=duration&start=2025-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4472000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#575269 Filing: 000162828026049834 The citation records this snapshot. The page link may show a newer release later.	USD 564,000 Exact value Exact value: 564000 USD 2025-05-01 – 2026-04-30: 564000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHAMPIONS ONCOLOGY, INC. · 2026-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Capital Expenditure: 564000 USD Concept: fundies:CapitalExpenditure Period: 2025-05-01 to 2026-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856/explain?concept=fundies%3ACapitalExpenditure&period=2026-04-30&surface=latest&period_type=duration&start=2025-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 564000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#577835 Filing: 000162828026049834 The citation records this snapshot. The page link may show a newer release later.	−USD 5.04 million Calculation and evidence -4472000 − 564000 USD Exact free cash flow: -5036000 USD 2025-05-01 – 2026-04-30: -4472000 USD · Inspect Operating Cash Flow · Source 2025-05-01 – 2026-04-30: 564000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHAMPIONS ONCOLOGY, INC. · 2026-04-30 CHAMPIONS ONCOLOGY, INC. (edgar:771856) Free cash flow: -5036000 USD Concept: free-cash-flow Period: 2025-05-01 to 2026-04-30 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/771856?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4472000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#575269 Filing: 000162828026049834 Input fundies:CapitalExpenditure: 564000 USD (2025-05-01 to 2026-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/771856/000162828026049834/csbr-20260430.htm#577835 Filing: 000162828026049834 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

143 filings · 4,237 latest values · 4,239 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000771856, 771856, CSBR, csbr, edgar:771856

Also known as CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS ONCOLOGY, INC., CHAMPIONS SPORTS INC

CHAMPIONS ONCOLOGY, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2026 2025-05-01 – 2026-04-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation